A new clinical trial underway in the Lowcountry is drawing attention for its unconventional — and potentially groundbreaking ...

The findings of the first study ever on how LSD (lysergic acid diethylamide) affects the brain have been released and its results might help LSD join ketamine a.k.a. "special K" as a treatment for ...

Researchers are investigating whether the drug could be used in mainstream medicine—with and without its hallucinatory effects.

A new study published last month examined the influence of LSD on brain connections, yielding some enlightening results. The study, published in the Journal of Psychopharmacology, found that the “drug ...

The magical and potent hallucinogen lysergic acid diethylamide (LSD) may have a new, clinically significant medical benefit: getting sleep. A new study, entitled “LSD Increases Sleep Duration the ...

In 1957, when the British psychiatrist Humprhey Osmond was looking to coin a word for the mind-bending effects of LSD, he wrote a letter to his friend Aldous Huxley. The "Brave New World" author — who ...

Recent analysis of federal health data suggests that the recreational use of LSD is associated with a lower likelihood of ...

Dropping acid can allay angst in those suffering terminal illness, a new survey has exposed. Noting that legalized used of LSD by U.S. psychiatrists slammed to a halt in 1966 after the mind-altering ...

Ongoing neuroscience research on psychedelic drugs like LSD and psilocybin is increasingly demonstrating the healing potential of these substances. In the case of LSD, researchers note in a recent ...

Would you pay money to support a scientific experiment involving illegal drugs? A group of British scientists started a crowdfunding campaign to raise the remaining 25,000 pounds (about $37,600) ...

BASEL, Switzerland, Feb. 17, 2021 /PRNewswire/ -- MindMed (NEO: MMED), (OTCQB: MMEDF), (DE: MMQ), a leading psychedelic medicine biotech company, announced the start of a study for its LSD neutralizer ...

BASEL, Switzerland, Feb. 17, 2021 /PRNewswire/ -- MindMed (NEO: MMED), (OTCQB: MMEDF), (DE: MMQ), a leading psychedelic medicine biotech company, announced the start of a study for its LSD neutralizer ...